PANCREATIC ADENOCARCINOMA METASTATIC
Clinical trials for PANCREATIC ADENOCARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOCARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOCARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smart drug home in on Hard-to-Treat cancers?
Disease control OngoingThis trial is testing an experimental drug called XNW27011 in people with advanced solid tumors, such as pancreatic, lung, ovarian, colorectal, biliary tract, stomach, or gastroesophageal junction cancer, that have not responded to or are not eligible for standard treatments. XNW…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New cocktail aims to outsmart pancreatic Cancer's defenses
Disease control OngoingThis study tests whether adding two experimental drugs (elraglusib and losartan) to standard chemotherapy (FOLFIRINOX) can prevent metastatic pancreatic cancer from becoming resistant to treatment. About 70 adults with untreated, advanced pancreatic cancer will receive the combin…
Matched conditions: PANCREATIC ADENOCARCINOMA METASTATIC
Phase: PHASE2 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC